BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 18076025)

  • 1. Computational prediction of the binding site of proteinase 3 to the plasma membrane.
    Hajjar E; Mihajlovic M; Witko-Sarsat V; Lazaridis T; Reuter N
    Proteins; 2008 Jun; 71(4):1655-69. PubMed ID: 18076025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How does proteinase 3 interact with lipid bilayers?
    Broemstrup T; Reuter N
    Phys Chem Chem Phys; 2010 Jul; 12(27):7487-96. PubMed ID: 20532386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis of the membrane insertion domain of proteinase 3, the Wegener's autoantigen, in RBL cells: implication for its pathogenic activity.
    Kantari C; Millet A; Gabillet J; Hajjar E; Broemstrup T; Pluta P; Reuter N; Witko-Sarsat V
    J Leukoc Biol; 2011 Nov; 90(5):941-50. PubMed ID: 21821719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping of conformational epitopes on human proteinase 3, the autoantigen of Wegener's granulomatosis.
    Kuhl A; Korkmaz B; Utecht B; Kniepert A; Schönermarck U; Specks U; Jenne DE
    J Immunol; 2010 Jul; 185(1):387-99. PubMed ID: 20530264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in the substrate binding sites of murine and human proteinase 3 and neutrophil elastase.
    Hajjar E; Korkmaz B; Reuter N
    FEBS Lett; 2007 Dec; 581(29):5685-90. PubMed ID: 18023421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The crystal structure of PR3, a neutrophil serine proteinase antigen of Wegener's granulomatosis antibodies.
    Fujinaga M; Chernaia MM; Halenbeck R; Koths K; James MN
    J Mol Biol; 1996 Aug; 261(2):267-78. PubMed ID: 8757293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coexpression of CD177 and membrane proteinase 3 on neutrophils in antineutrophil cytoplasmic autoantibody-associated systemic vasculitis: anti-proteinase 3-mediated neutrophil activation is independent of the role of CD177-expressing neutrophils.
    Hu N; Westra J; Huitema MG; Bijl M; Brouwer E; Stegeman CA; Heeringa P; Limburg PC; Kallenberg CG
    Arthritis Rheum; 2009 May; 60(5):1548-57. PubMed ID: 19404956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis-induced proteinase 3 membrane expression is independent from degranulation.
    Durant S; Pederzoli M; Lepelletier Y; Canteloup S; Nusbaum P; Lesavre P; Witko-Sarsat V
    J Leukoc Biol; 2004 Jan; 75(1):87-98. PubMed ID: 14525959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epitopes on proteinase-3 recognized by antibodies from patients with Wegener's granulomatosis.
    Williams RC; Staud R; Malone CC; Payabyab J; Byres L; Underwood D
    J Immunol; 1994 May; 152(9):4722-37. PubMed ID: 8157982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of PR3-ANCA associated vasculitis.
    Kallenberg CG
    J Autoimmun; 2008; 30(1-2):29-36. PubMed ID: 18162369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional significance of Asn-linked glycosylation of proteinase 3 for enzymatic activity, processing, targeting, and recognition by anti-neutrophil cytoplasmic antibodies.
    Specks U; Fass DN; Finkielman JD; Hummel AM; Viss MA; Litwiller RD; McDonald CJ
    J Biochem; 2007 Jan; 141(1):101-12. PubMed ID: 17158864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inspection of the binding sites of proteinase3 for the design of a highly specific substrate.
    Hajjar E; Korkmaz B; Gauthier F; Brandsdal BO; Witko-Sarsat V; Reuter N
    J Med Chem; 2006 Feb; 49(4):1248-60. PubMed ID: 16480262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane-bound proteinase 3 and its receptors: relevance for the pathogenesis of Wegener's Granulomatosis.
    Hu N; Westra J; Kallenberg CG
    Autoimmun Rev; 2009 May; 8(6):510-4. PubMed ID: 19185066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased membrane expression of proteinase 3 during neutrophil adhesion in the presence of anti proteinase 3 antibodies.
    Brachemi S; Mambole A; Fakhouri F; Mouthon L; Guillevin L; Lesavre P; Halbwachs-Mecarelli L
    J Am Soc Nephrol; 2007 Aug; 18(8):2330-9. PubMed ID: 17634439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structures of human proteinase 3 and neutrophil elastase--so similar yet so different.
    Hajjar E; Broemstrup T; Kantari C; Witko-Sarsat V; Reuter N
    FEBS J; 2010 May; 277(10):2238-54. PubMed ID: 20423453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophil-derived proteinase 3 induces kallikrein-independent release of a novel vasoactive kinin.
    Kahn R; Hellmark T; Leeb-Lundberg LM; Akbari N; Todiras M; Olofsson T; Wieslander J; Christensson A; Westman K; Bader M; Müller-Esterl W; Karpman D
    J Immunol; 2009 Jun; 182(12):7906-15. PubMed ID: 19494315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of proteinase 3 with its associated partners: implications in the pathogenesis of Wegener's granulomatosis.
    Witko-Sarsat V; Reuter N; Mouthon L
    Curr Opin Rheumatol; 2010 Jan; 22(1):1-7. PubMed ID: 19881350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human proteinase 3 (PR3) and its binding molecules: implications for inflammatory and PR3-related autoimmune responses.
    Müller A; Voswinkel J; Gottschlich S; Csernok E
    Ann N Y Acad Sci; 2007 Aug; 1109():84-92. PubMed ID: 17785293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. d-Peptides as inhibitors of PR3-membrane interactions.
    Maximova K; Venken T; Reuter N; Trylska J
    Biochim Biophys Acta Biomembr; 2018 Feb; 1860(2):458-466. PubMed ID: 29132840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A substrate-based approach to convert SerpinB1 into a specific inhibitor of proteinase 3, the Wegener's granulomatosis autoantigen.
    Jégot G; Derache C; Castella S; Lahouassa H; Pitois E; Jourdan ML; Remold-O'Donnell E; Kellenberger C; Gauthier F; Korkmaz B
    FASEB J; 2011 Sep; 25(9):3019-31. PubMed ID: 21670065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.